Total Payments
$17,981
2024 Payments
$2,028
Companies
39
Transactions
829
Medicare Patients
4,751
Medicare Billing
$425,365
Payment Breakdown by Category
Food & Beverage$16,582 (92.2%)
Travel$1,259 (7.0%)
Education$139.11 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,582 | 817 | 92.2% |
| Travel and Lodging | $1,259 | 6 | 7.0% |
| Education | $139.11 | 6 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,747 | 122 | $0 (2024) |
| Gilead Sciences, Inc. | $2,745 | 82 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,439 | 70 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $1,285 | 8 | $0 (2017) |
| ABBVIE INC. | $1,230 | 64 | $0 (2024) |
| Lilly USA, LLC | $1,163 | 70 | $0 (2024) |
| PFIZER INC. | $1,108 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $836.48 | 46 | $0 (2022) |
| Novo Nordisk Inc | $807.73 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $617.89 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,028 | 96 | ABBVIE INC. ($374.36) |
| 2023 | $2,385 | 118 | AbbVie Inc. ($505.75) |
| 2022 | $1,872 | 90 | AstraZeneca Pharmaceuticals LP ($324.67) |
| 2021 | $1,596 | 87 | Gilead Sciences, Inc. ($251.16) |
| 2020 | $1,532 | 76 | Gilead Sciences, Inc. ($316.52) |
| 2019 | $2,615 | 111 | Gilead Sciences, Inc. ($748.94) |
| 2018 | $2,146 | 113 | AstraZeneca Pharmaceuticals LP ($353.30) |
| 2017 | $3,807 | 138 | VERTEX PHARMACEUTICALS INCORPORATED ($1,285) |
All Payment Transactions
829 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: HIV | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY, TRADJENTA | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.22 | General |
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: HIV | ||||||
| 09/04/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardio-renal | ||||||
| 09/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.62 | General |
| 08/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,258 | 1,884 | $447,315 | $119,562 |
| 2022 | 16 | 1,219 | 1,738 | $374,420 | $96,040 |
| 2021 | 14 | 1,249 | 1,902 | $415,305 | $115,061 |
| 2020 | 14 | 1,025 | 1,543 | $373,275 | $94,702 |
Total Patients
4,751
Total Services
7,067
Medicare Billing
$425,365
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 414 | $165,600 | $41,240 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 188 | 188 | $47,000 | $26,664 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 307 | $99,775 | $19,796 | 19.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 154 | 282 | $63,450 | $11,293 | 17.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $10,800 | $7,638 | 70.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 216 | 392 | $19,600 | $3,293 | 16.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 77 | 78 | $5,855 | $2,640 | 45.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $12,600 | $2,589 | 20.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $2,040 | $1,151 | 56.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $5,525 | $968.25 | 17.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 42 | 42 | $4,200 | $916.56 | 21.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 12 | $1,800 | $486.60 | 27.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 26 | 29 | $5,800 | $470.38 | 8.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 18 | $2,250 | $275.21 | 12.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $1,020 | $141.24 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 305 | $122,000 | $28,069 | 23.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 146 | 146 | $36,500 | $21,274 | 58.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 157 | 270 | $87,780 | $18,126 | 20.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 135 | 236 | $53,105 | $9,872 | 18.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 37 | 37 | $11,100 | $4,882 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 88 | 89 | $5,595 | $2,998 | 53.6% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 57 | 57 | $8,550 | $2,541 | 29.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $10,650 | $2,330 | 21.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 36 | 36 | $2,160 | $1,223 | 56.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 211 | 391 | $19,560 | $1,159 | 5.9% |
About Dr. John Yee, MD
Dr. John Yee, MD is a General Practice healthcare provider based in Everett, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407810856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Yee, MD has received a total of $17,981 in payments from pharmaceutical and medical device companies, with $2,028 received in 2024. These payments were reported across 829 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($16,582).
As a Medicare-enrolled provider, Yee has provided services to 4,751 Medicare beneficiaries, totaling 7,067 services with total Medicare billing of $425,365. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Everett, MA
- Active Since 04/13/2006
- Last Updated 06/29/2010
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407810856
Products in Payments
- JARDIANCE (Drug) $1,313
- VRAYLAR (Drug) $966.85
- BEVESPI AEROSPHERE (Drug) $963.94
- FARXIGA (Drug) $796.80
- ELIQUIS (Drug) $728.50
- XARELTO (Drug) $666.96
- BREZTRI (Drug) $557.83
- Descovy (Drug) $435.90
- Ozempic (Drug) $390.50
- APRETUDE (Biological) $377.09
- ENTRESTO (Drug) $371.92
- CHANTIX (Drug) $342.74
- TRULICITY (Drug) $307.09
- SPIRIVA RESPIMAT (Drug) $264.79
- Truvada (Drug) $240.39
- MYRBETRIQ (Drug) $224.12
- ANORO (Drug) $207.21
- Kerendia (Drug) $189.50
- MOUNJARO (Drug) $177.09
- EMGALITY (Drug) $175.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Everett
Elizabeth Covino
General Practice — Payments: $7,120
General Practice $7,120
Dr. Randal Franke, M.d, M.D
General Practice — Payments: $5,478
General Practice $5,478
Lauren Mouchati, Np, NP
General Practice — Payments: $2,831
General Practice $2,831
Dr. Micaela Dea, Dds, DDS
General Practice — Payments: $2,514
General Practice $2,514
Dr. Paul Serrano, Dmd, DMD
General Practice — Payments: $2,302
General Practice $2,302
Charles Kim, Dds, DDS
General Practice — Payments: $2,226
General Practice $2,226